Overview

GUIDELINES Pocketcard is a tri-fold pocketcard containing society-endorsed, evidence-based treatment guidelines in a brief algorithmic format that is most preferred by practicing clinicians, quality managers, nurses, educators, and medical students.1, 2 The Bone-Modifying Agents in Metastatic Breast Cancer GUIDELINES Pocketcard is endorsed by the American Society of Clinical Oncology (ASCO) and based on their latest guidelines. This practical quick-reference tool includes timing of therapy, a management algorithm, FDA-approved drug list, toxicities and safety concerns-all the essential components from ASCO's full-text guidelines-and is approved by the ASCO Practice Guidelines Committee. The Bone-Modifying Agents in Metastatic Breast Cancer GUIDELINES Pocketcard provides all that is needed to make accurate clinical decisions at the point of care including: Key Points; Indications and Timing of Therapy; Role of BMAs in the Presence of Extraskeletal Metastases; Laboratory Monitoring; Drug Toxicities and Risks; Osteonecrosis of the Jaw; Role of BMAs in Pain Control; Management Algorithm; Current Medication Tables with Brand and Generic Names. Applications: point-of-care, education, QI interventions, clinical trials, medical reference, clinical research. 12007 PDR Physician Survey. 2VA-HHS national guidelines attribute preference survey.

Full Product Details

9780984642397

Table of Contents

Reviews

Author Information

A tax exempt, not-for-profit organization, the American Society of Clinical Oncology (ASCO) was founded in 1964 by a small group of physician members of the American Association of Cancer Research (AACR) who recognized the need for the creation of a separate society dedicated to issues unique to clinical oncology. ASCO has more than 27,000 members worldwide. Its membership is comprised of clinical oncologists from all oncology disciplines and subspecialties including medical oncology, therapeutic radiology, surgical oncology, pediatric oncology, gynecologic oncology, urologic oncology, and hematology; physicians and health care professionals participating in approved oncology training programs; oncology nurses; and other health care practitioners with a predominant interest in oncology.

Tab Content 6

Customer Reviews

Recent Reviews

Countries Available